Association between anti-tuberculosis drug resistance-conferring mutations and treatment outcomes in Myanmar

Infect Dis (Lond). 2018 May;50(5):388-390. doi: 10.1080/23744235.2017.1404632. Epub 2017 Dec 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents*
  • Humans
  • Mutation
  • Myanmar
  • Mycobacterium tuberculosis
  • Treatment Outcome
  • Tuberculosis*

Substances

  • Antitubercular Agents